Approvals/NMPA/Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Approved

生物制品

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

北京生物制品研究所有限责任公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeYYf7I9
Approval Number: 国药准字S20171001
Generic Name: 口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗(人二倍体细胞)
Generic Name En: Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral
Drug Type: 生物制品
Dosage Form: 口服溶液剂
Strength: 每瓶0.5ml(5人份)。每1次人用剂量为2滴(相当于0.1ml),含脊髓灰质炎活病毒总量应不低于6.12lgCCID50,其中Ⅰ型应不低于6.0lgCCID50,Ⅲ型应不低于5.5lgCCID50。
Reg Date: 2020-10-30
Company Name: 北京生物制品研究所有限责任公司
Company Address: 北京市北京经济技术开发区博兴二路9号院4号楼2层205室
Production Company Name: 北京生物制品研究所有限责任公司
Production Company Address: 北京市北京经济技术开发区博兴二路6、9号
Company Detail Path: /organization/bei-jing-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si
Production Company Detail Path: /organization/bei-jing-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 30, 2020

Approval ID

7LeaeYYf7I9

Type

生物制品